[Epidemiology, diagnosis and treatment of Middle East respiratory syndrome]

Yu Zhang1, Shao-hua Chen2

  • 1Department of Oncology, Zhejiang Hospital, Hangzhou 310013 China.

Insights

Middle East respiratory syndrome (MERS) is a global health concern. Understanding MERS coronavirus (MERS-CoV) transmission and pathogenesis is crucial for developing effective prevention strategies.

Area of Science:

  • * Virology
  • * Epidemiology
  • * Public Health

Background:

  • * Middle East respiratory syndrome (MERS) poses a significant global public health risk.
  • * The Middle East respiratory syndrome coronavirus (MERS-CoV) has caused over 1,300 confirmed cases across 26 countries.
  • * MERS-CoV is a zoonotic virus with incompletely understood pathogenesis and transmission routes.

Purpose of the Study:

  • * To summarize the current understanding of MERS-CoV epidemiology and transmission.
  • * To highlight the role of the spike glycoprotein in MERS-CoV infection.
  • * To emphasize the need for prophylactic strategies against MERS-CoV.

Main Methods:

  • * Review of reported MERS-CoV cases and epidemiological data.
  • * Analysis of MERS-CoV transmission patterns, including zoonotic and human-to-human spread.
  • * Examination of the molecular mechanisms of MERS-CoV, focusing on the spike glycoprotein.

Main Results:

  • * As of June 19, 2015, 1,338 MERS-CoV cases were reported globally.
  • * Most cases are linked to travel or residence in the Middle East.
  • * Human-to-human transmission has been observed but is generally not sustainable.

Conclusions:

  • * MERS-CoV remains a public health concern requiring further investigation.
  • * The spike glycoprotein is a key factor in MERS-CoV pathogenesis.
  • * Effective prophylactic strategies are essential for controlling MERS-CoV outbreaks.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
633
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
319
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
493
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
864
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.1K